# Min-Hee Ryu

Source: https://onco.cc/people/ryu-min-hee/  
OnCo record `ryu-min-hee` (Person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Min-Hee Ryu is a gastric cancer and GIST trialist central to the Asian arms of ramucirumab, pembrolizumab, and zolbetuximab studies.

## Summary

Min-Hee Ryu is Professor of Medical Oncology at Asan Medical Center in Seoul, specialising in gastric cancer and gastrointestinal stromal tumours. He co-leads gastrointestinal oncology at the centre and has been central to the Asian arms of the ramucirumab, pembrolizumab and zolbetuximab studies, with steering roles in RAINBOW-Asia, GLOW and the KEYNOTE gastric trials, as well as in studies of tyrosine kinase inhibitor sequencing in GIST. His publications include the GLOW trial of zolbetuximab plus CAPOX in Claudin 18.2-positive gastric or gastro-oesophageal junction adenocarcinoma. His interests are gastric cancer, GIST and clinical trials.

## Fields

- Kind: Person
- Last checked: 2026-09-08
- Role: Professor of Medical Oncology; gastric cancer and GIST
- Specialisms: Gastric cancer; GIST; Clinical trials

## Sources

- Asan Medical Center: https://eng.amc.seoul.kr
- PubMed author search: https://pubmed.ncbi.nlm.nih.gov/?term=Ryu%20MH%5BAuthor%5D%20Asan%20gastric

## Connected records

- cancers: [Gastric & gastro-oesophageal junction cancer](https://onco.cc/cancers/gastric/), [Sarcomas (soft tissue, bone, GIST)](https://onco.cc/cancers/sarcoma/)
- targets: [Claudin 18.2](https://onco.cc/targets/cldn18-2/)
- drugs: [Ramucirumab](https://onco.cc/drugs/ramucirumab/), [Zolbetuximab](https://onco.cc/drugs/zolbetuximab/)
- institutions: [Asan Medical Center](https://onco.cc/institutions/asan-medical-center/)
- trials: [RAINBOW](https://onco.cc/trials/rainbow/), [SPOTLIGHT & GLOW](https://onco.cc/trials/spotlight-glow/)

---
JSON: https://onco.cc/api/v1/entities/ryu-min-hee.json